Tivic Health Systems, Inc., today announced it has acquired worldwide exclusive license rights from Statera Biopharma to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimodtm for the ...

The stock makes the NASDAQ top percentage gainer list on news , currently trading at 0.5316, up 0.2966, gaining 126.2128% on ...

Today was a big day for one small cap biotech company. The company announced that they had acquired worldwide exclusive ...

Schrödinger will report its fourth quarter and full-year 2024 financial results on Wednesday, February 26, 2025, after the financial markets close. The company will host a conference call and webcast ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars ...

After hours: February 7 at 7:56:34 PM EST Loading Chart for SPRY ...

Acute respiratory distress syndrome (ARDS) is associated with high morbidity and mortality but lacks specific therapeutic options. Diverse endocytic processes play a key role in all phases of acute ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

In this Clinical Outlook, we describe available multiomic studies in cardiovascular medicine, discuss the advantages and potential of multiomic techniques for clinical translation in cardiology ...

to explore the use of human ghrelin as a countermeasure against radiation-induced gastrointestinal syndrome (GI-ARS). Led by Dr Ping Wang, chief scientific officer and senior vice-president ...

Opaganib is an investigational oral SPHK2 selective inhibitor “targeting multiple potential indications, including several cancers, diabetes and obesity-related disorders, gastrointestinal acute ...